Journal profile · PHARMACOLOGY & PHARMACY
Jundishapur Journal of Natural Pharmaceutical Products
ISSN 1735-7780 · eISSN 2228-7876 · Kowsar Publishing Company
Jundishapur Journal of Natural Pharmaceutical Products: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; 83 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Jundishapur Journal of Natural Pharmaceutical Products is published by Kowsar Publishing Company and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Medicinal Plant Research, Essential Oils and Antimicrobial Activity and Advanced Drug Delivery Systems, together about 36.9% of its articles. Its main subfields are Plant Science. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medicinal Plant ResearchAgricultural and Biological Sciences19.8%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences10.7%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics6.5%
- Natural Antidiabetic Agents StudiesMedicine4.6%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences4.5%
- Phytochemistry Medicinal Plant ApplicationsAgricultural and Biological Sciences3.9%
- Complementary and Alternative Medicine StudiesMedicine3.6%
- Phytochemicals and Antioxidant ActivitiesMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Pharmacology, Toxicology and Pharmaceutics | Q3 | 42/79 | 47th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.2LetPub ·
- SJR 2026-06
- 0.28LetPub ·
- SNIP 2026-06
- 0.47LetPub ·
- h-index
- 37OpenAlex ·
- i10-index
- 204OpenAlex ·
- 2-year mean citedness
- 1.42OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 97.27%LetPub ·
Volume
- Articles per year
- 76LetPub ·
Articles by year OpenAlex count · 883 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 63 | 63 | 526 |
| 2025 | 83 | 83 | 798 |
| 2024 | 61 | 61 | 836 |
| 2023 | 53 | 53 | 814 |
| 2022 | 27 | 27 | 774 |
| 2021 | 76 | 76 | 754 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
Too few articlesOnly 1 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Kowsar Publishing Company
- ISSN
- 1735-7780
- Electronic ISSN
- 2228-7876
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Jundishapur Journal of Natural Pharmaceutical Products
What CAS zone is Jundishapur Journal of Natural Pharmaceutical Products in?
In the 2025 upgraded edition of the CAS Journal Ranking, Jundishapur Journal of Natural Pharmaceutical Products is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
Which databases index Jundishapur Journal of Natural Pharmaceutical Products?
According to LetPub and DOAJ records, Jundishapur Journal of Natural Pharmaceutical Products is indexed in ESCI and Scopus.
Is Jundishapur Journal of Natural Pharmaceutical Products open access, and what is the APC?
Jundishapur Journal of Natural Pharmaceutical Products is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .